NCT07756606 Evaluating the Impacts of Informal Tick and Tickborne Disease Educational Tools on Children
| NCT ID | NCT07756606 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Tick Bites |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2026-10-18 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2026-10-18 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the impacts of informal educational tools used by the Midwest Center of Excellence for Vector-Borne Disease in collaboration with the Wisconsin Department of Health Services. Children aged 6-12 will receive an educational activity about ticks. They will be asked questions before and after the activity and will participate for between 10-20 minutes.
Eligibility Criteria
Inclusion Criteria: * children aged 6-12 years old Exclusion Criteria: * less than 6 years old or greater than 12 years old
Contact & Investigator
Susan Paskewitz, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT07756606 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Tick Bites. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07756606 currently recruiting?
Yes, NCT07756606 is actively recruiting participants. Contact the research team at chalvorsen2@wisc.edu for enrollment information.
Where is the NCT07756606 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT07756606 clinical trial?
NCT07756606 is sponsored by University of Wisconsin, Madison. The principal investigator is Susan Paskewitz, PhD at University of Wisconsin, Madison. The trial plans to enroll 1,000 participants.